National Institutes of Health (NIH) Director Francis Collins stated yesterday that the agency does not have the authority to use its “march-in” rights as a tool to lower drug prices. …
CMS finalized yesterday a nearly 30 percent cut in Medicare Part B reimbursement to hospitals for 340B physician-administered drugs. The payment cut will go into effect January 1, 2018. Currently,…
Last week, President Trump declared the opioid epidemic a national public health emergency. The declaration allows federal agencies “to use every appropriate emergency authority to fight the opioid crisis.” The…
The House Energy & Commerce Subcommittee on Oversight and Investigations held its second hearing on the 340B drug program last Wednesday. Five covered entities – including RWC-340B member AIDS Resource…
This week, 57 Senators signed a bipartisan letter to CMS urging the agency to reconsider its proposal to reduce Medicare Part B reimbursement for 340B drugs. The proposed rule would…
HRSA sent a new proposed rule on 340B Ceiling Price and Manufacturer Civil Monetary Penalties (CMPs) to the White House Office of Management and Budget (OMB) for review on October…
The House Energy and Commerce (E&C) Committee will hold a hearing focused on the 340B program before the Oversight and Investigations Subcommittee on Wednesday, October 11 at 10 a.m. The hearing…
Tom Price announced his resignation as HHS Secretary on Friday amid criticism concerning his use of private jets funded by taxpayer dollars. The White House has named Don J. Wright,…
Members of Congress have signed onto a bipartisan letter to CMS urging the agency to abandon its proposal to reduce Medicare Part B reimbursement for 340B drugs. 228 members of…
RWC-340B joined the 340B Coalition in submitting comments to the Health Resources and Services Administration opposing the additional delay of the 340B Ceiling Price and Manufacturer Civil Penalties Final Rule.…